Electronic Investigator Site Files

17 November 2026

Introduction

During GCP inspections, inspectors frequently identify deviations related to the establishment, use, management and archiving of electronic Investigator Site Files (eISFs).

These deviations concern both investigators/institutions and sponsors, particularly where electronic solutions are provided, selected or managed by the sponsor or a service provider acting on behalf of the sponsor.

According to ICH E6(R3), Annex 1 (2.12.11) The investigator/institution should maintain the trial records as specified in Appendix C and as required by the applicable regulatory requirement(s). The investigator/institution should have control of all essential records generated by the investigator/institution before and during the conduct of the trial. According to Annex 1 (2.12.12), the investigator/institution should retain the essential records for the required retention period in accordance with applicable regulatory requirements or until the sponsor informs the investigator/institution that these records are no longer needed, whichever is the longest.

ICH E6(R3) Appendix C (C.2.3) states that essential records should be maintained in, or referred to from, repositories held by the sponsor and investigator/institution for their respective records. The repository held by the investigator/institution may be referred to as the Investigator Site File (ISF).

ICH E6(R3) Appendix C (C.1.3) further states that the investigator/institution should have access to and the ability to maintain the essential records generated by the investigator/institution before and during trial conduct.

The use of an electronic system, or the sponsor’s facilitation (e.g. by financing or hosting via third party) of the investigator’s use of an electronic Investigator Site File does not change the respective responsibilities of the investigator/institution and the sponsor for essential records. It does also not change that to preserve record/data integrity, it is essential to maintain segregation of duties and responsibilities, i.e. the sponsor should not have undue control of investigator site files as per Principle 9, including 9.4 and 9.5, and Annex 1, section 3.16.1 (l).

 

Can electronic Investigator Site Files be used?

Yes. An ISF may be maintained electronically by sites, provided that the electronic filing arrangements enable both the investigator/institution and sponsor to fulfil their respective responsibilities as described in ICH E6.

ICH E6 recognises that essential records may be maintained in different repositories. It requires storage systems to provide an index covering all relevant repositories and location of investigator’s essential records, appropriate identification, version history, search and retrieval of trial records.

In addition, ICH E6(R3) Annex 1 section 4 and the EU GCP IWG guideline on computerised systems and electronic data should be complied with. It addresses requirements and expectations concerning, among other things, data integrity, validation, audit trails, user management, security and electronic signatures, and specifies who is responsible for compliance with such requirements.

More specifically, this means that the investigator is responsible for maintaining their essential records and for maintaining control over the eISF as referenced in the introduction above, and in accordance with ICH E6(R3) Annex 1, section 2.12.10 (c), the investigator is also responsible for ensuring that the requirements in section 4 of the ICH E6(R3) are proportionately addressed. The sponsor on the other hand is responsible for assessing the fitness for purpose of the investigator’s choice of electronic Investigator Site File, where deployed by the investigator as per ICH E6(R3) Annex 1, section 3.16.1.x. (vi).  

 

Can the sponsor facilitate the use of an eISF by the investigator/institution?

Yes. The sponsor can facilitate the use of an eISF by the investigator/institution, provided that the decision right and control of the investigator is respected and with due respect for the segregation of duties that is needed to preserve the record/data integrity.

The sponsor may contract and pay for the electronic Investigator Site File; however, this should not result in inappropriate sponsor control over investigator/institution records.

According to ICH E6(R3) Annex 1, section 2.3.1, the investigator may delegate trial-related activities to other persons or parties. The investigator may be supported by the sponsor in the identification of a suitable service provider(s); however, the investigator retains the final decision on whether the service provider intended to support the investigator is appropriate based on information provided by the sponsor.

Likewise, according to section 3.6.5 the sponsor should provide information to the investigator on any service provider identified by the sponsor to undertake any activities under the responsibility of the investigator. The responsibility for such activities remains with the investigator.  

Consequently, it is the decision of the investigator to use (or not) an electronic Investigator Site File facilitated or provided by the sponsor, and the sponsor should respect the investigator’s decision to e.g. use a paper Investigator Site File, should the investigator choose so. The sponsor should not put undue pressure on the investigator site to use an electronic Investigator Site File e.g. by making this a condition for cooperation.

For paper ISF maintenance the usual practice has been that the site retains control over the access to the ISF during the trial by keeping the ISF in the institution and allowing the sponsor’s representative (the monitor) access to the ISF during monitoring visits. The monitor has also typically brought documents to the site, thereby helping in assisting in the maintenance of the ISF; while the maintenance has remained the responsibility of the investigator.

With regards to archiving, it has historically been accepted by the DKMA that sponsors contract and pay for offsite archiving facilities. This has been allowed if it has been contractually ensured between the sponsor, the investigator and the archiving facility that only the investigator can request retrieval of the paper ISF and that the sponsor cannot access the archived ISF.

Should the investigator choose to use an electronic Investigator Site File facilitated or even deployed by the sponsor (via an independent service provider) this should not result in less control by the investigator than in the paper scenario described above. Consequently, it should be clear from the contractual arrangements and other communication between the investigator, the service provider and the sponsor that this is the choice of the investigator and that the investigator is aware of/trained in the legal requirements and the responsibility in accordance with Annex 1, section 2.12. Further, as for the paper scenario, the sponsor should not have inappropriate accesses to the eISF during and after the trial. This should be ensured by both the investigator’s, the sponsor’s and the service provider’s processes for access management. 

 

Who has the responsibility for the computerised system

Where the system is deployed by the investigator/institution, the investigator has the full responsibility for ensuring that the system complies with the requirements in ICH E6(R3) Annex 1 section 4 and the EU GCP IWG guideline on computerised systems and electronic data.

In this regard, the DKMA would like to point out that a risk-based approach could be taken by the investigator with regards to assessment of fitness for purpose/validation of an eISF. According to the EU guideline on computerised systems and electronic data, systems used for other purposes than what they were developed for, or which are used outside the supplier’s specification/validation are inherently higher risk

This means that if a well-established computerised system is used as intended, this assessment can often be limited to encompass critical functionality for a system; whereas, if the investigator chooses to use a customised system or systems that are not developed for that intended use, more in-depth validation assessments are required by the investigator.

Where the system is deployed by the sponsor (via an independent service provider), the sponsor has the full responsibility for ensuring that the system complies with the requirements in ICH E6(R3) Annex 1 section 4 and the EU GCP IWG guideline on computerised systems and electronic data.

 

Do some systems inherently not fulfil requirements for an eISF?

The investigator should be aware that dumps of files with various essential records into an external hard drive or a dedicated part of the institution’s usual drives (even if access restricted) do not fulfil ICH E6(R3) and EU guidelines’ requirements for e.g. audit trail and should not be used as an eISF.

Individual essential records, such as a service provider providing an independent copy to the investigator of e.g. ePRO data and metadata related to the participants at the investigator site at the end of the trial, may (based on risk and where appropriately protected) be provided on a USB, CD or other media containing no other essential records. The investigator may rely on such records for retention purposes, if the exported dataset constitutes a complete and verified copy, if data are accompanied by relevant metadata, and if the data integrity can be demonstrated. The retained archival medium, should be managed under appropriate sponsor and institutional procedures covering e.g. responsibility, storage location, access controls, backup, periodic integrity and readability checks, and replacement or migration of the medium throughout the retention period.

Before withdrawing the investigator’s access to such a system (e.g. ePRO or EDC system), the sponsor must ensure that investigator obtains a complete independent copy of the data and associated metadata required for retention, with sufficient time to review it.

 

What are the expectations where an investigator is tasked with downloading their records?

According to Annex 1, section 3.16.1 (k and m), the sponsor should ensure that the investigator has timely access to data, including for archiving purposes. Where an investigator is required by the sponsor to download their data, records and relevant metadata from a computerised system deployed by the sponsor to an appropriate repository (e.g. where a sponsor provides a portal for distribution of records to an investigator or where an investigator needs to download local copies of for example drug accountability records from an IRT system), this process should be supported by clearly defined procedures, provided by the sponsor to the site, and appropriate verification of completeness, timeliness and accuracy.

The risk to data, the operational feasibility, the workload imposed on the investigators and the adequacy of the controls should be assessed and documented as part of the trial’s risk assessment process. This is to minimise the risk of missing records or relevant metadata.

The sponsor should ensure that the investigator can download appropriate formats of records, data and relevant metadata.

The mechanism used to provide the investigator with a complete copy of the data and associated metadata should be commensurate with the volume and complexity of the information to be transferred. Therefore, although manual download may be acceptable for limited datasets, for example documentation relating to a small number of SUSARs made available through a portal, it would generally not be considered acceptable for the transfer of all eCRF or ePRO data for a site unless measures are in place to ensure that the process does not impose a disproportionate administrative burden on the site and to ensure the completeness of the transfer.

 

 

What are frequent deviations given by inspectors with regards to electronic Investigator Site Files?

The DKMA GCP inspectors frequently give significant (major/critical) deviations related to electronic Investigator Trial Files. The deviations are primarily directed towards investigators as they are ultimately responsible for the Investigators Site Files; however, the sponsors are in many cases considered co-responsible, as they do also have responsibilities in this regard, e.g. for not coercing sites, for introducing unnecessary burden on sites or for not performing an appropriate fitness for purpose assessment of a site’s computerised systems used in a clinical trial.

Examples of frequent deviations given by inspectors with regards to electronic Investigator Site Files include but are not limited to the following:

  • Lack of fitness for purpose assessment (by the investigator and/or the sponsor) of computerised systems used for storage of essential records during and after a trial.
  • Inappropriate qualification of eISFs
  • Use of inappropriate storage medium (e.g. dumps of records, data and relevant metadata to an external hard drive or a department’s internal drive) by an investigator
  • Provision of inappropriate formats of data and metadata to sites, e.g. audit trail and other relevant metadata not being available
  • Inappropriate storage formats, e.g. when decommissioning systems with dynamic functionalities
  • Lack of oversight of essential records, i.e. missing an appropriate and complete index covering all relevant repositories
  • Lack of investigator control of or access to essential records
  • Lack of – or inappropriate - access control for eISFs, e.g. by providing inappropriate accesses to sponsor representatives, inappropriate administrator privileges
  • System functionality not supporting appropriate segregation of responsibilities
  • Undue coercion by the sponsor to use an eISF
  • Lack of training of investigator site staff in the use of an eISF
  • Insufficient IT security measures and/or backup
  • eISFs not being maintained throughout the trial, e.g. large-scale retrospective uploading of records
  • Inappropriate arrangements for decommissioning, e.g. not ensuring that the investigator has the time and possibility to verify their independent copy
  • Burdensome downloading procedures by the sites
  • Inadequate procedures for ensuring the completeness of transfers of data and metadata

At stated in the introduction, these deviations concern both investigators/institutions and sponsors depending on who has the responsibility for the system and the process in question.

 

17 November 2026